Cargando…

How ADA methodology informs SARS-CoV-2 assay development

Detalles Bibliográficos
Autor principal:	Becker, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Newlands Press Ltd 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491572/ https://www.ncbi.nlm.nih.gov/pubmed/32915061 http://dx.doi.org/10.4155/bio-2020-0220

Ejemplares similares

Novel pathogenic ADA2 mutations: alert to diagnosis challenge of ADA2 deficiency
por: Wu, Zhijie, et al.
Publicado: (2023)

Methodological Development of a Multi-Readout Assay for the Assessment of Antiviral Drugs against SARS-CoV-2
por: Hahn, Friedrich, et al.
Publicado: (2021)

HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
por: Fleury, Herve
Publicado: (2022)

How Antivirals Might be Linked to the Emergence of New Variants of SARS-CoV-2
por: Mehdizadeh, Ali Reza, et al.
Publicado: (2021)

How SARS-CoV-2 Big Data Are Challenging Viral Taxonomy Rules
por: Focosi, Daniele, et al.
Publicado: (2023)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

SARS-CoV-2 docet
por: Sarli, Leopoldo
Publicado: (2021)

Development of an immunofluorescence assay for detection of SARS-CoV-2
por: Atiya-Nasagi, Yafit, et al.
Publicado: (2022)

Performance of the LIAISON(®) SARS-CoV-2 Antigen Assay vs. SARS-CoV-2-RT-PCR
por: Fiedler, Melanie, et al.
Publicado: (2021)

The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2
por: Morris, Kevin V.
Publicado: (2020)

Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine
por: Matsuzaka, Yasunari, et al.
Publicado: (2023)

How did SARS-CoV-2 changed the landscape in cancer care
por: Adamakidou, Theodoula, et al.
Publicado: (2022)

Is the Patient Infected with SARS-CoV-2?
por: Klausner, Jeffrey D., et al.
Publicado: (2021)

Fundamentals of SARS-CoV-2 Biosensors
por: Torres-Torres, Carlos, et al.
Publicado: (2022)

Terrific cells for SARS-CoV-2
por: Gottschalk, Stephen
Publicado: (2022)

Can an effective SARS-CoV-2 vaccine be developed for the older population?
por: Pawelec, Graham, et al.
Publicado: (2020)

How SOLID is the immune system’s response to the deadly duo of lung cancer and SARS-CoV-2?
por: Narvel, Hiba, et al.
Publicado: (2022)

The SARS-CoV-2 epidemic: how the Italian public is being informed
por: Antonelli, G., et al.
Publicado: (2020)

Music of Microbiota Against SARS CoV-2
por: Belojevic, Goran, et al.
Publicado: (2019)

Focus on SARS-CoV-2 and COVID-19
por: Chen, Sharon C-A., et al.
Publicado: (2020)

In Pursuit of a SARS-CoV-2 Vaccine
por: Johnson, Alton R., et al.
Publicado: (2020)

Mental health and the SARS-CoV-2 pandemic
por: Crespo-Facorro, Benedicto
Publicado: (2020)

SARS-CoV2 vaccines: Slow is fast
por: Green, Douglas R.
Publicado: (2020)

SARS-CoV-2: Herausforderung für alle
por: Holz, Frank G.
Publicado: (2020)

Mental health and the SARS-CoV-2 pandemic
por: Crespo-Facorro, Benedicto
Publicado: (2020)

Origins of SARS-CoV-2: Focusing on Science
por: Shi, Zheng-Li
Publicado: (2021)

The Importance of Research on the Origin of SARS-CoV-2
por: Lundstrom, Kenneth, et al.
Publicado: (2020)

SARS-CoV-2 and its infected world
Publicado: (2021)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine
por: Wilder-Smith, Annelies, et al.
Publicado: (2021)

Diabetes mellitus and SARS-CoV-2 infection()
por: Alonso, Núria, et al.
Publicado: (2021)

Scientific evidence on the origin of SARS-CoV-2
por: Domingo, Jose L.
Publicado: (2021)

Reflections on a Year of SARS-CoV-2
por: Abeles, Elisabeth, et al.
Publicado: (2021)

SARS-CoV2 vaccine boosters for India
por: Kang, Gagandeep
Publicado: (2022)

The SARS-CoV-2 vaccines: Retrospective and perspectives
por: Epaulard, Olivier
Publicado: (2022)

Updates in Management of SARS-CoV-2 Infection
por: Flisiak, Robert, et al.
Publicado: (2022)

SARS-CoV-2, COVID-19 and Neurodegeneration
por: Tönges, Lars, et al.
Publicado: (2022)

Scientific evidence on the origin of SARS-CoV-2
por: Núñez-Delgado, Avelino, et al.
Publicado: (2023)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

ADA Research Funding in 2009: Where Will We Be?
por: Robertson, R. Paul
Publicado: (2009)

ADA Research Funding in 2009: Where Will We Be?
por: Robertson, R. Paul
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ugu6ofmmen4s0np71iotqefb7f